Trial intelligence / Profile preview

XM17 vs Gonal-f in women undergoing superovulation

2009-017674-20Phase 3Completed

Sponsor
BioGeneriX AG
Start
Dec 2009
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised trial of follitropin in female infertility (2 arms), sponsored by BioGeneriX AG. Primary endpoint: Number of oocytes retrieved in the main study. Started Dec 2009; status: completed.

02

Drugs

follitropin
03

Conditions

female infertility

Beyond the preview

Go deeper on 2009-017674-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-017674-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call